MedMira Inc. (MIR.V)
TSXV · CAD · Healthcare · Biotechnology
CA$0.05 (+0.00%) as of
Key statistics
- Market cap
- 35.09M
- EPS (TTM)
- -0.0000
- Dividend yield
- 0.00%
- 52-week range
- 0.0500 – 0.0900
- Beta
- 0.78
- Revenue (TTM)
- 370.57k
- Profit margin
- 0.00%
- Volume
- 10.00k
About MedMira Inc.
MedMira Inc., a biotechnology company, researches, develops, manufactures, and sells rapid diagnostics and technology platforms in North America, Europe, and internationally. The company offers Reveal HIV, a test that detects antibodies to HIV-1 and HIV-2 in whole blood, serum, or plasma; Reveal TP, a rapid syphilis antibody test that detects treponema pallidum antibodies in serum, plasma, or whole blood; Multiplo, a line of multiplex tests for HIV-1/2, Hepatitis B and C, and syphilis; and Miriad triple product for preliminary screening of HIV and hepatitis. It also provides the Miriad RVF toolkit, which facilitates the development and commercialization of rapid diagnostics; and Reveal G4 HIV tests. The company was founded in 1993 and is headquartered in Halifax, Canada. MedMira Inc. is a subsidiary of MedMira Holding AG.
- Sector
- Healthcare
- Industry
- Biotechnology
- Headquarters
- Halifax, NS, Canada
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.